Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Liver”

5,175 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,175 results

Testing effectiveness (Phase 2)UnknownNCT03803436
What this trial is testing

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

Who this might be right for
Liver MetastasesColorectal Cancer MetastaticLiver Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Not applicableLooking for participantsNCT02864485
What this trial is testing

Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
University Health Network, Toronto 20
Large-scale testing (Phase 3)Looking for participantsNCT04868149
What this trial is testing

Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS

Who this might be right for
Liver Cancer
The University of Hong Kong 40
Testing effectiveness (Phase 2)Looking for participantsNCT06695026
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Rznomics, Inc. 45
Large-scale testing (Phase 3)UnknownNCT04509635
What this trial is testing

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

Who this might be right for
Colorectal CancerLiver MetastasesCetuximab
Fudan University 50
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Not applicableStudy completedNCT04880772
What this trial is testing

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

Who this might be right for
Cancer of ColonCancer of RectumLiver Metastases
East Lancashire Hospitals NHS Trust 42
Not applicableLooking for participantsNCT07310537
What this trial is testing

Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling

Who this might be right for
Colorectal Cancer (Diagnosis)Colorectal Liver Metastasis (CRLM)Circulating Tumor DNA (ctDNA)
Erasmus Medical Center 35
Testing effectiveness (Phase 2)Ended earlyNCT00787787
What this trial is testing

Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
University of Washington 41
Not applicableLooking for participantsNCT00034216
What this trial is testing

Collection of Blood From Patients With Cancer

Who this might be right for
Prostate CancerBreast CancerColon Cancer+2 more
National Cancer Institute (NCI) 1,750
Not applicableStudy completedNCT02880306
What this trial is testing

Hepatocellular Carcinoma and Rheumatoid Arthritis

Who this might be right for
Carcinoma, Hepatocellular
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 741,379
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07157306
What this trial is testing

Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Early research (Phase 1)Study completedNCT00327652
What this trial is testing

Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases

Who this might be right for
Neoplasm MetastasisLiver NeoplasmsCarcinoma
Anza Therapeutics, Inc. 9
Not applicableWithdrawnNCT00892255
What this trial is testing

Microwave Ablation of Resectable Liver Tumors

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
St. Joseph Hospital of Orange
Not applicableStudy completedNCT03746392
What this trial is testing

Project to Improve Communication About Serious Illness - Pilot Study

Who this might be right for
Malignant NeoplasmLeukemia, Lymphocytic, Chronic, B-CellLung Disease Chronic+7 more
University of Washington 150
Testing effectiveness (Phase 2)Study completedNCT02195011
What this trial is testing

Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases

Who this might be right for
Colorectal Neoplasms
SCRI Development Innovations, LLC 26
Testing effectiveness (Phase 2)Study completedNCT01271504
What this trial is testing

E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eisai Inc. 102
Not applicableEnded earlyNCT00923052
What this trial is testing

The Natural History of Solid Organ Cancer Stem Cells (SOCSC)

Who this might be right for
Hepatic CancerPancreatic Ductal CancerColorectal Cancer+2 more
National Cancer Institute (NCI) 190
Testing effectiveness (Phase 2)Study completedNCT01639352
What this trial is testing

Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Lynn Feun 20
Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Load More Results